AC Immune SA - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 2834 www.acimmune.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

Top Penny Stocks To Watch In January 2026 - Jan 13th, 2026 11:05 am
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week - Jan 8th, 2026 5:47 am
Startup Lifordi Seeks to Deliver Potent Medication for Autoimmune Diseases - Dec 26th, 2025 8:00 am
Discovering Opportunities: AirJoule Technologies Among 3 Promising Penny Stocks - Dec 12th, 2025 5:04 am
AC Immune posts positive data for Parkinson’s immunotherapy - Dec 11th, 2025 6:36 am
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease - Dec 11th, 2025 5:00 am
Here's Why We're Watching AC Immune's (NASDAQ:ACIU) Cash Burn Situation - Dec 5th, 2025 4:08 am
AC Immune to Present at the Jefferies 2025 London Healthcare Conference - Nov 11th, 2025 5:00 am
AC Immune (ACIU): Losses Narrow 5.9% Annually; Revenue Growth Forecast at 55.6% Pre-Earnings - Nov 4th, 2025 8:22 pm
AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates - Nov 4th, 2025 6:55 am
AC Immune: Q3 Earnings Snapshot - Nov 4th, 2025 5:48 am
AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - Nov 4th, 2025 5:00 am
AC Immune And 2 Other Promising Penny Stocks - Oct 31st, 2025 6:05 am
Alector (ALEC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Oct 29th, 2025 8:00 am
Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline - Oct 28th, 2025 8:00 am
AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board - Oct 28th, 2025 5:00 am
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine - Oct 24th, 2025 6:50 am
Intellia Therapeutics (NTLA) Soars 19.7%: Is Further Upside Left in the Stock? - Oct 9th, 2025 7:23 am
Why AC Immune (ACIU) Is Up 15.8% After Promising Early Trial Data for Alzheimer’s Vaccine Candidate - Oct 9th, 2025 3:09 am
A Look at AC Immune’s (NasdaqGM:ACIU) Valuation After New Alzheimer’s Immunotherapy Trial Results - Oct 7th, 2025 6:38 am